Who
Joshua Silverman
Chief Executive Officer
Company insider
Files Form 4 as: Executive Chairman, Q/C Technologies; Chief Executive Officer, Fabric.AI; Director, Petros Pharmaceuticals; Executive Chairman, Tao Synergies; CEO and President, PharmaCyte Biotech; Director, Femasys; Director, Neurotrope; Director, Performance Technologies.
In numbers
- Trades disclosed
- 159
- Buys
- 12
- Sells
- 12
- Bought
- $493K
- Sold
- $272K
- Companies
- 12
- Companies where not an officer
- 8
- First trade
- 8 Dec 2011
- Last trade
- 1 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —77,390 at $0.00 | filing |
| 30 Sep 2026filed 16 Oct 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code F | $102K44,820 at $2.28 | filing |
| 10 Jul 2026filed 2 Oct 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —16,620 at $0.00 | filing |
| 30 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code F | $165K44,820 at $3.69 | filing |
| 30 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code F | $165K44,820 at $3.69 | filing |
| 18 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code A | —358,565 at $0.00 | filing |
| 18 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code F | $166K44,820 at $3.70 | filing |
| 18 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code A | —358,565 at $0.00 | filing |
| 18 Jun 2026filed 14 Aug 2026 | FABC Fabric.AITelecom Carriers | SEC FORM 4 Code F | $166K44,820 at $3.70 | filing |
| 5 Jun 2026filed 5 Jun 2026 | Petros PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —4,375,000 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | Petros PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —4,375,000 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | TAOX Tao Synergiesoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | TAOX Tao Synergiesoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 13 Apr 2026filed 2 Oct 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —16,806 at $0.00 | filing |
| 13 Apr 2026filed 2 Oct 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —162,162 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C Technologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | QCLS Q/C TechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —162,162 at $0.00 | filing |
| 7 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $33K40,000 at $0.8329 | filing |
News
PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 2% – Here's WhyPMCB · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Joshua Silverman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.